Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 16, 2007 - Issue 7
Submit an article Journal homepage
264
Views
92
CrossRef citations to date
0
Altmetric
Review

Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas

Maikel Wijtmans Vrije Universiteit Amsterdam, Leiden/Amsterdam Center of Drug Research (LACDR), Division of Medicinal Chemistry, Faculty of Sciences, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands +31 20 5987600; +31 20 5987610; [email protected]
,
Rob Leurs Vrije Universiteit Amsterdam, Leiden/Amsterdam Center of Drug Research (LACDR), Division of Medicinal Chemistry, Faculty of Sciences, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands +31 20 5987600; +31 20 5987610; [email protected]
&
Iwan de Esch Vrije Universiteit Amsterdam, Leiden/Amsterdam Center of Drug Research (LACDR), Division of Medicinal Chemistry, Faculty of Sciences, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands +31 20 5987600; +31 20 5987610; [email protected]
Pages 967-985 | Published online: 26 Jun 2007

Citations (92)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Qirong Li, Xinyi Zhang, Qiang Feng, Hengzong Zhou, Chaoyang Ma, Chao Lin, Dongxu Wang & Jianmei Yin. (2023) Common Allergens and Immune Responses Associated with Allergic Rhinitis in China. Journal of Asthma and Allergy 16, pages 851-861.
Read now
Sebastiaan Kuhne, Maikel Wijtmans, Herman D Lim, Rob Leurs & Iwan JP de Esch. (2011) Several down, a few to go: histamine H3 receptor ligands making the final push towards the market?. Expert Opinion on Investigational Drugs 20:12, pages 1629-1648.
Read now
Graham Beaton & Wilna J Moree. (2010) The expanding role of H1 antihistamines: a patent survey of selective and dual activity compounds 2005 – 2010. Expert Opinion on Therapeutic Patents 20:9, pages 1197-1218.
Read now
Dorota Łażewska & Katarzyna Kieć-Kononowicz. (2010) Recent advances in histamine H3 receptor antagonists/inverse agonists. Expert Opinion on Therapeutic Patents 20:9, pages 1147-1169.
Read now
Róbert Kiss & György M Keseru˝. (2009) Histamine H4 receptor ligands and their potential therapeutic applications. Expert Opinion on Therapeutic Patents 19:2, pages 119-135.
Read now
Nir Barak. (2008) Betahistine: what's new on the agenda?. Expert Opinion on Investigational Drugs 17:5, pages 795-804.
Read now

Articles from other publishers (86)

Anil Karbhari Shinde, Rajesh Kumar Badange, Veena Reballi, Pramod Kumar Achanta, Kumar Bojja, Sravanthi Manchineella, Nageswara Rao Muddana, Ramkumar Subramanian, Raghava Choudary Palacharla, Vijay Benade, Pradeep Jayarajan, Jagadeesh Babu Thentu, Bujji Babu Lingavarapu, Sivasekhar Yarra, Narendra Kagita, Mallikarjuna Rao Doguparthi, Abdul Rasheed Mohammed & Ramakrishna Nirogi. (2021) 1‐[2‐(1‐Cyclobutylpiperidin‐4‐yloxy)‐6,7‐dihydro‐4 H ‐thiazolo[5,4‐ c ]pyridin‐5‐yl]propan‐1‐one: a Histamine H 3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition . ChemMedChem 17:3.
Crossref
Suhyun Lim, Iwah Jeong, Jonghyeok Cho, Chaewon Shin, Kwan-Il Kim, Bum-Sang Shim, Seong-Gyu Ko & Bonglee Kim. (2021) The Natural Products Targeting on Allergic Rhinitis: From Traditional Medicine to Modern Drug Discovery. Antioxidants 10:10, pages 1524.
Crossref
Nakisa Ghamari, Omid Zarei, José-Antonio Arias-Montaño, David Reiner, Siavoush Dastmalchi, Holger Stark & Maryam Hamzeh-Mivehroud. (2019) Histamine H3 receptor antagonists/inverse agonists: Where do they go?. Pharmacology & Therapeutics 200, pages 69-84.
Crossref
Tamara A. M. Mocking, Maurice C. M. L. Buzink, Rob Leurs & Henry F. Vischer. (2019) Bioluminescence Resonance Energy Transfer Based G Protein-Activation Assay to Probe Duration of Antagonism at the Histamine H3 Receptor. International Journal of Molecular Sciences 20:15, pages 3724.
Crossref
Tom H. Johnston, Alix M.B. Lacoste, Naomi P. Visanji, Anthony E. Lang, Susan H. Fox & Jonathan M. Brotchie. (2019) Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease. Neuropharmacology 147, pages 11-27.
Crossref
Tamara A. M. Mocking, Eléonore W. E. Verweij, Henry F. Vischer & Rob Leurs. (2018) Homogeneous, Real-Time NanoBRET Binding Assays for the Histamine H 3 and H 4 Receptors on Living Cells . Molecular Pharmacology 94:6, pages 1371-1381.
Crossref
Elden Berla Thangam, Ebenezer Angel Jemima, Himadri Singh, Mirza Saqib Baig, Mahejibin Khan, Clinton B. Mathias, Martin K. Church & Rohit Saluja. (2018) The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets. Frontiers in Immunology 9.
Crossref
Tony J. Masri, Vikas Jain & Christian Guilleminault. 2018. Fatigue Management. Fatigue Management 125 140 .
Juraj Velcicky, Wolfgang Miltz, Berndt Oberhauser, David Orain, Andrea Vaupel, Klaus Weigand, Janet Dawson King, Amanda Littlewood-Evans, Mark Nash, Roland Feifel & Pius Loetscher. (2017) Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and Angiogenesis. Journal of Medicinal Chemistry 60:9, pages 3672-3683.
Crossref
Henk Timmerman, Rob Leurs & Henk van der Goot. 2017. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Robert L. Hudkins, John A. Gruner, Rita Raddatz, Joanne R. Mathiasen, Lisa D. Aimone, Michael J. Marino, Edward R. Bacon, Michael Williams & Mark A. Ator. (2016) 3-(1′-Cyclobutylspiro[4H-1,3-benzodioxine-2,4′-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist. Neuropharmacology 106, pages 37-45.
Crossref
Christophe Genicot & Laurent Provins. 2016. Lead Generation. Lead Generation 513 546 .
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 247 263 .
Zhongli Gao, William J. Hurst, Daniel Hall, Ryan Hartung, William Reynolds, Jiesheng Kang, Raisa Nagorny, James A. Hendrix & Pascal G. George. (2015) Design and synthesis of a novel series of histamine H3 receptor antagonists through a scaffold hopping strategy. Bioorganic & Medicinal Chemistry 23:3, pages 429-438.
Crossref
Katarina Nikolic, Slavica Filipic, Danica Agbaba & Holger Stark. (2014) Procognitive Properties of Drugs with Single and Multitargeting H 3 Receptor Antagonist Activities . CNS Neuroscience & Therapeutics 20:7, pages 613-623.
Crossref
Naveen Khatri & A.K. Madan. (2014) Models for H3 receptor antagonist activity of sulfonylurea derivatives. Journal of Molecular Graphics and Modelling 48, pages 87-95.
Crossref
Robert L. Hudkins, Kurt A. Josef, Nadine C. Becknell, Lisa D. Aimone, Jacquelyn A. Lyons, Joanne R. Mathiasen, John A. Gruner & Rita Raddatz. (2014) Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): Histamine H3 receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity. Bioorganic & Medicinal Chemistry Letters 24:5, pages 1303-1306.
Crossref
Arne Mørk, Liliana P. Montezinho, Silke Miller, Crista Trippodi-Murphy, Niels Plath, Yan Li, Maria Gulinello & Connie Sanchez. (2013) Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats. Pharmacology Biochemistry and Behavior 105, pages 41-50.
Crossref
John J. Renger. 2012. Sleep Deprivation, Stimulant Medications, and Cognition. Sleep Deprivation, Stimulant Medications, and Cognition 152 164 .
. 2012. Sleep Deprivation, Stimulant Medications, and Cognition. Sleep Deprivation, Stimulant Medications, and Cognition 58 183 .
Federica Vacondio, Claudia Silva, Lisa Flammini, Vigilio Ballabeni, Elisabetta Barocelli & Marco Mor. (2012) Brain Pharmacokinetics of Non‐Imidazole Biphenyl H3 Receptor Antagonists: a Liquid Chromatography/Electrospray‐Mass Spectrometry and ex vivo Binding Study in Rats . Chemistry & Biodiversity 9:7, pages 1231-1239.
Crossref
Javier Ceras, Nuria Cirauqui, Silvia Pérez-Silanes, Ignacio Aldana, Antonio Monge & Silvia Galiano. (2012) Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies. European Journal of Medicinal Chemistry 52, pages 1-13.
Crossref
Kurt A. Josef, Lisa D. Aimone, Jacquelyn Lyons, Rita Raddatz & Robert L. Hudkins. (2012) Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 22:12, pages 4198-4202.
Crossref
Ramakrishna Nirogi, Vishwottam Kandikere, Gopinadh Bhyrapuneni, Nageswararao Muddana, Ramanatha Saralaya, Ranjith Kumar Ponnamaneni & Arun Kumar Manoharan. (2012) In vivo receptor occupancy assay of histamine H3 receptor antagonist in rats using non-radiolabeled tracer. Journal of Pharmacological and Toxicological Methods 65:3, pages 115-121.
Crossref
Ashwin U. Rao, Ning Shao, Robert G. Aslanian, Tin-Yau Chan, Sylvia J. Degrado, Li Wang, Brian McKittrick, Mary Senior, Robert E. WestJr.Jr., Shirley M. Williams, Ren-Long Wu, Joyce Hwa, Bhuneshwari Patel, Shuqin Zheng, Christopher Sondey & Anandan Palani. (2011) Discovery of a Potent Thiadiazole Class of Histamine H 3 Receptor Antagonist for the Treatment of Diabetes . ACS Medicinal Chemistry Letters 3:3, pages 198-202.
Crossref
Reddeppa Reddy Dandu, Jacquelyn A. Lyons, Rita Raddatz, Zeqi Huang, Lisa D. Aimone & Robert L. Hudkins. (2012) Synthesis and evaluation of a new series of 1?-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4?-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists. Bioorganic & Medicinal Chemistry Letters 22:6, pages 2151-2153.
Crossref
Robert L. Hudkins, Allison L. Zulli, Reddeppa reddy Dandu, Ming Tao, Kurt A. Josef, Lisa D. Aimone, R. Curtis Haltiwanger, Zeqi Huang, Jacquelyn A. Lyons, Joanne R. Mathiasen, Rita Raddatz & John A. Gruner. (2012) 4-Phenoxypiperidine pyridazin-3-one histamine H3 receptor inverse agonists demonstrating potent and robust wake promoting activity. Bioorganic & Medicinal Chemistry Letters 22:4, pages 1504-1509.
Crossref
Ming Tao, Lisa D. Aimone, Zeqi Huang, Joanne Mathiasen, Rita Raddatz, Jacquelyn Lyons & Robert L. Hudkins. (2011) Optimization of 5-Pyridazin-3-one Phenoxypropylamines as Potent, Selective Histamine H 3 Receptor Antagonists with Potent Cognition Enhancing Activity . Journal of Medicinal Chemistry 55:1, pages 414-423.
Crossref
Ming Tao, Lisa D. Aimone, John A. Gruner, Joanne R. Mathiasen, Zeqi Huang, Jacquelyn Lyons, Rita Raddatz & Robert L. Hudkins. (2012) Synthesis and structure–activity relationship of 5-pyridazin-3-one phenoxypiperidines as potent, selective histamine H3 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 22:2, pages 1073-1077.
Crossref
Robert L. Hudkins, Lisa D. Aimone, Reddeppa reddy Dandu, Derek Dunn, John A. Gruner, Zeqi Huang, Kurt A. Josef, Jacquelyn A. Lyons, Joanne R. Mathiasen, Ming Tao, Allison L. Zulli & Rita Raddatz. (2012) 4,5-Dihydropyridazin-3-one derivatives as histamine H3 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 22:1, pages 194-198.
Crossref
Rogier A. Smits, Herman D. Lim, Tiffany van der Meer, Sebastiaan Kuhne, Karin Bessembinder, Obbe P. Zuiderveld, Maikel Wijtmans, Iwan J.P. de Esch & Rob Leurs. (2012) Ligand based design of novel histamine H4 receptor antagonists; fragment optimization and analysis of binding kinetics. Bioorganic & Medicinal Chemistry Letters 22:1, pages 461-467.
Crossref
Reddeppa reddy Dandu, John A. Gruner, Joanne R. Mathiasen, Lisa D. Aimone, Greg Hostetler, Caitlyn Benfield, Robert J. Bendesky, Val R. Marcy, Rita Raddatz & Robert L. Hudkins. (2011) Synthesis and evaluation of pyridazinone–phenethylamine derivatives as selective and orally bioavailable histamine H3 receptor antagonists with robust wake-promoting activity. Bioorganic & Medicinal Chemistry Letters 21:21, pages 6362-6365.
Crossref
Ming Tao, Rita Raddatz, Lisa D. Aimone & Robert L. Hudkins. (2011) Synthesis and structure–activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 21:20, pages 6126-6130.
Crossref
Robert L. Hudkins, Lisa D. Aimone, Thomas R. Bailey, Robert J. Bendesky, Reddeppa reddy Dandu, Derek Dunn, John A. Gruner, Kurt A. Josef, Yin-Guo Lin, Jacquelyn Lyons, Val R. Marcy, Joanne R. Mathiasen, Babu G. Sundar, Ming Tao, Allison L. Zulli, Rita Raddatz & Edward R. Bacon. (2011) Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity. Bioorganic & Medicinal Chemistry Letters 21:18, pages 5493-5497.
Crossref
Tanya L. Wallace, Theresa M. Ballard, Bruno Pouzet, Wim J. Riedel & Joseph G. Wettstein. (2011) Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacology Biochemistry and Behavior 99:2, pages 130-145.
Crossref
Robert L. Hudkins, Rita Raddatz, Ming Tao, Joanne R. Mathiasen, Lisa D. Aimone, Nadine C. Becknell, Catherine P. Prouty, Lars J. S. Knutsen, Mehran Yazdanian, Gilbert Moachon, Mark A. Ator, John P. Mallamo, Michael J. Marino, Edward R. Bacon & Michael Williams. (2011) Discovery and Characterization of 6-{4-[3-( R )-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2 H -pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H 3 Receptor Inverse Agonist . Journal of Medicinal Chemistry 54:13, pages 4781-4792.
Crossref
Federica Vacondio, Claudia Silva, Giovanni Morini, Fabrizio Bordi, Lisa Flammini, Elisabetta Barocelli & Marco Mor. (2011) Liquid chromatography-mass spectrometric method for determination of the non-imidazole H 3 -receptor antagonist UPR1056 in rat plasma . Journal of Separation Science 34:14, pages 1656-1663.
Crossref
Daniel J. Pippel, John E. Mills, Chennagiri R. Pandit, Lana K. Young, Hua M. Zhong, Frank J. Villani & Neelakandha S. Mani. (2011) First, Second, and Third Generation Scalable Syntheses of Two Potent H 3 Antagonists . Organic Process Research & Development 15:3, pages 638-648.
Crossref
Rob Leurs, Henry F. Vischer, Maikel Wijtmans & Iwan J.P. de Esch. (2011) En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family. Trends in Pharmacological Sciences 32:4, pages 250-257.
Crossref
Maikel Wijtmans, Chris de Graaf, Gerdien de Kloe, Enade P. Istyastono, Judith Smit, Herman Lim, Ratchanok Boonnak, Saskia Nijmeijer, Rogier A. Smits, Aldo Jongejan, Obbe Zuiderveld, Iwan J. P. de Esch & Rob Leurs. (2011) Triazole Ligands Reveal Distinct Molecular Features That Induce Histamine H 4 Receptor Affinity and Subtly Govern H 4 /H 3 Subtype Selectivity . Journal of Medicinal Chemistry 54:6, pages 1693-1703.
Crossref
Meredith Broderick & Christian Guilleminault. 2011. Sleepiness. Sleepiness 444 451 .
Michael Berlin, Christopher W. Boyce & Manuel de Lera Ruiz. (2010) Histamine H 3 Receptor as a Drug Discovery Target . Journal of Medicinal Chemistry 54:1, pages 26-53.
Crossref
Adam J. DavenportClemens MöllerAlexander HeifetzMichael P. MazanetzRichard J. LawAndreas EbnethMark J. Gemkow. (2010) Using Electrophysiology and In Silico Three-Dimensional Modeling to Reduce Human Ether-à-go-go Related Gene K + Channel Inhibition in a Histamine H3 Receptor Antagonist Program . ASSAY and Drug Development Technologies 8:6, pages 781-789.
Crossref
James T. Anderson, Michael Campbell, Jianmin Wang, Kurt R. Brunden, John J. Harrington, Alain Stricker-Krongrad, Jianping Song, Chris Doucette, Steven Murphy & Youssef L. Bennani. (2010) Investigation of 4-piperidinols as novel H3 antagonists. Bioorganic & Medicinal Chemistry Letters 20:21, pages 6246-6249.
Crossref
H.G.F. Richter, C. Freichel, J. Huwyler, T. Nakagawa, M. Nettekoven, J.-M. Plancher, S. Raab, O. Roche, F. Schuler, S. Taylor, C. Ullmer & R. Wiegand. (2010) Discovery of potent and selective histamine H3 receptor inverse agonists based on the 3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one scaffold. Bioorganic & Medicinal Chemistry Letters 20:19, pages 5713-5717.
Crossref
M. Walter, Y. von Coburg, K. Isensee, K. Sander, X. Ligneau, J.-C. Camelin, J.-C. Schwartz & H. Stark. (2010) Azole derivatives as histamine H3 receptor antagonists, Part I: Thiazol-2-yl ethers. Bioorganic & Medicinal Chemistry Letters 20:19, pages 5879-5882.
Crossref
Adam J. Davenport, Christopher C. Stimson, Massimo Corsi, Darshan Vaidya, Edward Glenn, Timothy D. Jones, Sarah Bailey, Mark J. Gemkow, Ulrike Fritz & David J. Hallett. (2010) Discovery of substituted benzyl tetrazoles as histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 20:17, pages 5165-5169.
Crossref
Huaqing Liu, Robert J. Altenbach, Gilbert J. Diaz, Arlene M. Manelli, Ruth L. Martin, Thomas R. Miller, Timothy A. Esbenshade, Jorge D. Brioni & Marlon D. Cowart. (2010) In vitro studies on a class of quinoline containing histamine H3 antagonists. Bioorganic & Medicinal Chemistry Letters 20:11, pages 3295-3300.
Crossref
Makoto Ishikawa, Rie Shinei, Fumikazu Yokoyama, Miki Yamauchi, Masayo Oyama, Kunihiro Okuma, Takako Nagayama, Kazuhiko Kato, Nobukazu Kakui & Yasuo Sato. (2010) Role of Hydrophobic Substituents on the Terminal Nitrogen of Histamine in Receptor Binding and Agonist Activity: Development of an Orally Active Histamine Type 3 Receptor Agonist and Evaluation of Its Antistress Activity in Mice. Journal of Medicinal Chemistry 53:9, pages 3840-3844.
Crossref
P. Van Ruitenbeek, A. Vermeeren & W.J. Riedel. (2010) Memory in humans is unaffected by central H1-antagonism, while objectively and subjectively measured sedation is increased. European Neuropsychopharmacology 20:4, pages 226-235.
Crossref
Frédéric Denonne, Franck Atienzar, Sylvain Célanire, Bernard Christophe, Frédérique Delannois, Christel Delaunoy, Marie-Laure Delporte, Véronique Durieu, Michel Gillard, Bénédicte Lallemand, Yves Lamberty, Geneviève Lorent, Alain Vanbellinghen, Nathalie Van houtvin, Valérie Verbois & Laurent Provins. (2010) Phenyl-oxazoles, a New Family of Inverse Agonists at the H 3 Histamine Receptor . ChemMedChem 5:2, pages 206-212.
Crossref
Maikel Wijtmans, Frédéric Denonne, Sylvain Célanire, Michel Gillard, Saskia Hulscher, Christel Delaunoy, Nathalie Van houtvin, Remko A. Bakker, Sabine Defays, Julien Gérard, Luc Grooters, Delphine Hubert, Henk Timmerman, Rob Leurs, Patrice Talaga, Iwan J. P. de Esch & Laurent Provins. (2010) Histamine H3 receptor ligands with a 3-cyclobutoxy motif: a novel and versatile constraint of the classical 3-propoxy linker. MedChemComm 1:1, pages 39.
Crossref
George M. Brenner & Craig W. Stevens. 2010. Pharmacology. Pharmacology 290 300 .
Gerold Bongers, Iwan de Esch & Rob Leurs. 2010. Histamine in Inflammation. Histamine in Inflammation 11 19 .
Dorota Łażewska, Małgorzata Więcek, Xavier Ligneau, Tim Kottke, Lilia Weizel, Roland Seifert, Walter Schunack, Holger Stark & Katarzyna Kieć-Kononowicz. (2009) Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. Bioorganic & Medicinal Chemistry Letters 19:23, pages 6682-6685.
Crossref
Rogier A. Smits, Rob Leurs & Iwan J.P. de Esch. (2009) Major advances in the development of histamine H4 receptor ligands. Drug Discovery Today 14:15-16, pages 745-753.
Crossref
Yuko Mitobe, Sayaka Ito, Takashi Mizutani, Tsuyoshi Nagase, Nagaaki Sato & Shigeru Tokita. (2009) Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies. Bioorganic & Medicinal Chemistry Letters 19:15, pages 4075-4078.
Crossref
Takahide Sasaki, Toshiyuki Takahashi, Tsuyoshi Nagase, Takashi Mizutani, Sayaka Ito, Yuko Mitobe, Yasuhisa Miyamoto, Maki Kanesaka, Ryo Yoshimoto, Takeshi Tanaka, Norihiro Takenaga, Shigeru Tokita & Nagaaki Sato. (2009) Synthesis, structure–activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H3 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 19:15, pages 4232-4236.
Crossref
Sylvain Célanire, Maikel Wijtmans, Bernard Christophe, Philippe Collart, Iwan de Esch, Donald Dassesse, Christel Delaunoy, Frédéric Denonne, Véronique Durieu, Edith Gelens, Michel Gillard, Bénédicte Lallemand, Yves Lamberty, Florence Lebon, Jean-Marie Nicolas, Luc Quéré, Erwin Snip, Alain Vanbellinghen, Nathalie Van houtvin, Valérie Verbois, Henk Timmerman, Patrice Talaga, Rob Leurs & Laurent Provins. (2009) Discovery of a New Class of Non-imidazole Oxazoline-Based Histamine H 3 Receptor (H 3 R) Inverse Agonists . ChemMedChem 4:7, pages 1063-1068.
Crossref
J. Phillip Kennedy, P. Jeffrey Conn & Craig W. Lindsley. (2009) A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin. Bioorganic & Medicinal Chemistry Letters 19:12, pages 3204-3208.
Crossref
Herman D. Lim, Enade P. Istyastono, Andrea van de Stolpe, Giuseppe Romeo, Silvia Gobbi, Marjo Schepers, Roger Lahaye, Wiro M.B.P. Menge, Obbe P. Zuiderveld, Aldo Jongejan, Rogier A. Smits, Remko A. Bakker, Eric E.J. Haaksma, Rob Leurs & Iwan J.P. de Esch. (2009) Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: Synthesis, pharmacological evaluation, and cross-target QSAR studies. Bioorganic & Medicinal Chemistry 17:11, pages 3987-3994.
Crossref
Rob Leurs, Paul L Chazot, Fiona C Shenton, Herman D Lim & Iwan JP De Esch. (2009) Molecular and biochemical pharmacology of the histamine H4 receptor. British Journal of Pharmacology 157:1, pages 14-23.
Crossref
TR Miller, I Milicic, J Bauch, J Du, B Surber, KE Browman, K Marsh, M Cowart, JD Brioni & TA Esbenshade. (2009) Use of the H3 receptor antagonist radioligand [3H]-A-349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonists. British Journal of Pharmacology 157:1, pages 139-149.
Crossref
P Van Ruitenbeek, A Sambeth, A Vermeeren, SN Young & WJ Riedel. (2009) Effects of L-histidine depletion and L-tyrosine/L-phenylalanine depletion on sensory and motor processes in healthy volunteers. British Journal of Pharmacology 157:1, pages 92-103.
Crossref
Mark J. Gemkow, Adam J. Davenport, Silke Harich, Bart A. Ellenbroek, Andrea Cesura & David Hallett. (2009) The histamine H3 receptor as a therapeutic drug target for CNS disorders. Drug Discovery Today 14:9-10, pages 509-515.
Crossref
Dorota Łażewska, Kamil Kuder, Xavier Ligneau, Jean-Claude Camelin, Walter Schunack, Holger Stark & Katarzyna Kieć-Kononowicz. (2009) Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands. Bioorganic & Medicinal Chemistry 17:8, pages 3037-3042.
Crossref
Joseph LynchJrJr, Christopher Regan, Gary Stump, Pamela Tannenbaum, Joanne Stevens, Ashleigh Bone, David Gilberto, Colena Johnson, Naoko Fujino, Norihiro Takenaga, Shigeru Tokita, Tsuyoshi Nagase, Nagaaki Sato & John Renger. (2009) Hemodynamic and Cardiac Neurotransmitter-releasing Effects in Conscious Dogs of Attention- and Wake-promoting Agents: A Comparison of d-Amphetamine, Atomoxetine, Modafinil, and a Novel Quinazolinone H3 Inverse Agonist. Journal of Cardiovascular Pharmacology 53:1, pages 52-59.
Crossref
H. Timmerman & H. van der Goot. 2009. Encyclopedia of Neuroscience. Encyclopedia of Neuroscience 1149 1166 .
Martin K. Church. 2009. Allergy Frontiers: Classification and Pathomechanisms. Allergy Frontiers: Classification and Pathomechanisms 329 356 .
Rogier A. Smits, Iwan J. P. de Esch, Obbe P. Zuiderveld, Joachim Broeker, Kamonchanok Sansuk, Elena Guaita, Gabriella Coruzzi, Maristella Adami, Eric Haaksma & Rob Leurs. (2008) Discovery of Quinazolines as Histamine H 4 Receptor Inverse Agonists Using a Scaffold Hopping Approach . Journal of Medicinal Chemistry 51:24, pages 7855-7865.
Crossref
Marina I. Strakhova, Gerard B. Fox, Tracy L. Carr, David G. Witte, Timothy A. Vortherms, Arlene M. Manelli, Thomas R. Miller, Betty B. Yao, Jorge D. Brioni & Timothy A. Esbenshade. (2008) Cloning and characterization of the monkey histamine H3 receptor isoforms. European Journal of Pharmacology 601:1-3, pages 8-15.
Crossref
Takashi Mizutani, Tsuyoshi Nagase, Sayaka Ito, Yasuhisa Miyamoto, Takeshi Tanaka, Norihiro Takenaga, Shigeru Tokita & Nagaaki Sato. (2008) Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 18:23, pages 6041-6045.
Crossref
Giovanni Morini, Mara Comini, Mirko Rivara, Silvia Rivara, Fabrizio Bordi, Pier Vincenzo Plazzi, Lisa Flammini, Francesca Saccani, Simona Bertoni, Vigilio Ballabeni, Elisabetta Barocelli & Marco Mor. (2008) Synthesis and structure–activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. Bioorganic & Medicinal Chemistry 16:23, pages 9911-9924.
Crossref
Tsuyoshi Nagase, Takashi Mizutani, Etsuko Sekino, Shiho Ishikawa, Sayaka Ito, Yuko Mitobe, Yasuhisa Miyamoto, Ryo Yoshimoto, Takeshi Tanaka, Akane Ishihara, Norihiro Takenaga, Shigeru Tokita & Nagaaki Sato. (2008) Synthesis and Evaluation of Structurally Constrained Quinazolinone Derivatives as Potent and Selective Histamine H 3 Receptor Inverse Agonists . Journal of Medicinal Chemistry 51:21, pages 6889-6901.
Crossref
Robert J. Altenbach, Ronald M. Adair, Brian M. Bettencourt, Lawrence A. Black, Shannon R. Fix-Stenzel, Sujatha M. Gopalakrishnan, Gin C. Hsieh, Huaqing Liu, Kennan C. Marsh, Michael J. McPherson, Ivan Milicic, Thomas R. Miller, Timothy A. Vortherms, Usha Warrior, Jill M. Wetter, Neil Wishart, David G. Witte, Prisca Honore, Timothy A. Esbenshade, Arthur A. Hancock, Jorge D. Brioni & Marlon D. Cowart. (2008) Structure−Activity Studies on a Series of a 2-Aminopyrimidine-Containing Histamine H 4 Receptor Ligands . Journal of Medicinal Chemistry 51:20, pages 6571-6580.
Crossref
N Barak, F L Greenway, K Fujioka, L J Aronne & R F Kushner. (2008) Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial. International Journal of Obesity 32:10, pages 1559-1565.
Crossref
Makoto Jitsuoka, Daisuke Tsukahara, Sayaka Ito, Takeshi Tanaka, Norihiro Takenaga, Shigeru Tokita & Nagaaki Sato. (2008) Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 18:18, pages 5101-5106.
Crossref
Dorota Łażewska, Kamil Kuder, Xavier Ligneau, Jean-Charles Schwartz, Walter Schunack, Holger Stark & Katarzyna Kieć-Kononowicz. (2008) Piperidine variations in search for non-imidazole histamine H3 receptor ligands. Bioorganic & Medicinal Chemistry 16:18, pages 8729-8736.
Crossref
Simona Bertoni, Vigilio Ballabeni, Lisa Flammini, Francesca Saccani, Giuseppe Domenichini, Giovanni Morini, Mara Comini, Mirko Rivara & Elisabetta Barocelli. (2008) In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. Naunyn-Schmiedeberg's Archives of Pharmacology 378:3, pages 335-343.
Crossref
Tsuyoshi Nagase, Takashi Mizutani, Shiho Ishikawa, Etsuko Sekino, Takahide Sasaki, Takashi Fujimura, Sayaka Ito, Yuko Mitobe, Yasuhisa Miyamoto, Ryo Yoshimoto, Takeshi Tanaka, Akane Ishihara, Norihiro Takenaga, Shigeru Tokita, Takehiro Fukami & Nagaaki Sato. (2008) Synthesis, Structure−Activity Relationships, and Biological Profiles of a Quinazolinone Class of Histamine H 3 Receptor Inverse Agonists . Journal of Medicinal Chemistry 51:15, pages 4780-4789.
Crossref
Thomas R. MillerJohn L. BaranowskiBrian R. EstvanderDavid G. WitteTracy L. CarrArlene M. ManelliKathleen M. KruegerMarlon D. CowartJorge D. BrioniTimothy A. Esbenshade. (2008) A Robust and High-Capacity [ 35 S]GTP γ S Binding Assay for Determining Antagonist and Inverse Agonist Pharmacological Parameters of Histamine H 3 Receptor Ligands . ASSAY and Drug Development Technologies 6:3, pages 339-349.
Crossref
Donna M. Barten & Charles F. Albright. (2008) Therapeutic Strategies for Alzheimer’s Disease. Molecular Neurobiology 37:2-3, pages 171-186.
Crossref
Maikel Wijtmans, Sylvain Celanire, Erwin Snip, Michel R. Gillard, Edith Gelens, Philippe P. Collart, Bastiaan J. Venhuis, Bernard Christophe, Saskia Hulscher, Henk van der Goot, Florence Lebon, Henk Timmerman, Remko A. Bakker, Bénédicte I. L. F. Lallemand, Rob Leurs, Patrice E. Talaga & Iwan J. P. de Esch. (2008) 4-Benzyl-1 H -imidazoles with Oxazoline Termini as Histamine H 3 Receptor Agonists . Journal of Medicinal Chemistry 51:10, pages 2944-2953.
Crossref
Kerstin Sander, Tim Kottke & Holger Stark. (2008) Histamine H3 Receptor Antagonists Go to Clinics. Biological and Pharmaceutical Bulletin 31:12, pages 2163-2181.
Crossref
M. Hajós, C. J. Siok, W. E. Hoffmann, S. Li & B. Kocsis. (2008) Modulation of Hippocampal Theta Oscillation by Histamine H3 Receptors. Journal of Pharmacology and Experimental Therapeutics 324:1, pages 391-398.
Crossref
Robin L. Thurmond, Erwin W. Gelfand & Paul J. Dunford. (2008) The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nature Reviews Drug Discovery 7:1, pages 41-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.